Latest news
Trastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:42:22 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMTProphylactic Cranial Irradiation Improves Survival in Limited-Stage SCLC - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:08:44 GMTEnzalutamide Plus Leuprolide Improves Overall Survival in High-Risk Biochemically Recurrent Prostate Cancer - Vera HealthVera Health · Tue, 28 Jul 2026 09:07:41 GMTSonesitatug Vedotin Improves Overall Survival in CLDN18.2+ Gastric Cancer - CancerNetworkCancerNetwork · Mon, 27 Jul 2026 16:02:55 GMTSonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers - AstraZenecaAstraZeneca · Mon, 27 Jul 2026 07:00:00 GMTSonesitatug Vedotin Improves Overall Survival in Second- and Later-Line CLDN18.2-Positive Gastric/GEJ Cancer - OncLiveOncLive · Mon, 27 Jul 2026 07:00:00 GMT